You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Assess whether the adjuvanted vaccine offers a meaningful benefit in pregnant women in terms of immune response over the non-adjuvanted vaccine.

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

H1N1v Influenza Trial in Gentofte/Copenhagen, Næstved (Focetria)

Completed
  • H1N1v Influenza
  • Focetria
  • Gentofte, Denmark
  • +1 more
Nov 14, 2022

Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, FLU vaccine)

Active, not recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • FLU vaccine
  • Edegem, Belgium
  • +33 more
Dec 7, 2022

Cytomegalovirus Infections Trial in United States (Pentamer (low)/gB(low)/Adjuvant vaccine, Pentamer (med)/gB(low)/Adjuvant

Recruiting
  • Cytomegalovirus Infections
  • Pentamer (low)/gB(low)/Adjuvant vaccine
  • +4 more
  • Long Beach, California
  • +14 more
Jul 15, 2022

Flu Trial in Cleveland (Fluad Vaccine, Fluzone HD Vaccine)

Active, not recruiting
  • Flu
  • Fluad Vaccine
  • Fluzone HD Vaccine
  • Cleveland, Ohio
  • +1 more
May 20, 2022

Pregnancy Related Trial (Sangobion and Thiamine Hydrochloride, Sangobion, Thiamine HCl and Vitamin B12)

Recruiting
  • Pregnancy Related
  • Sangobion and Thiamine Hydrochloride
  • Sangobion, Thiamine hydrochloride and Vitamin B12
  • Mae Sot, Tak, Thailand
    Shoklo Malaria Research Unit (SMRU)
Oct 21, 2022

HIV-1 Trial in Worldwide (Ad26.Mos4.HIV, Clade C gp140, Placebo)

Completed
  • HIV-1
  • Ad26.Mos4.HIV
  • +2 more
  • Lilongwe, Malawi
  • +22 more
Apr 12, 2022

COVID-19 Trial in Adelaide (Spikogen/Covax-19)

Active, not recruiting
  • COVID-19
  • Spikogen/Covax-19
  • Adelaide, South Australia, Australia
    ARASMI
May 12, 2022

Chikungunya Trial in Fort Deterick, Silver Spring (Chikungunya)

Completed
  • Chikungunya
  • Chikungunya
  • Fort Deterick, Maryland
  • +1 more
Jan 4, 2022

SARS-CoV-2 Trial in Melbourne (Adjuvanted SARS-CoV-2 beta variant RBD recombinant protein vaccine (DoCo-Pro-RBD-1 + MF59),

Recruiting
  • SARS-CoV-2
  • Adjuvanted SARS-CoV-2 beta variant RBD recombinant protein vaccine (DoCo-Pro-RBD-1 + MF59)
  • +2 more
  • Melbourne, Victoria, Australia
  • +1 more
Apr 25, 2022

Influenza, Human Trial in Georgia, Turkey (aQIV, QIV)

Not yet recruiting
  • Influenza, Human
  • aQIV
  • QIV
  • Batumi, Georgia
  • +16 more
Oct 11, 2023

Zika Virus Infection Trial in Ponce (Placebo, Zika Virus Purified Inactivated Vaccine (ZPIV))

Completed
  • Zika Virus Infection
  • Placebo
  • Zika Virus Purified Inactivated Vaccine (ZPIV)
  • Ponce, Puerto Rico
    Ponce School of Medicine CAIMED Center
Apr 5, 2022

Hiv Trial in Amsterdam (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage)

Not yet recruiting
  • Hiv
  • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage
  • Amsterdam, Netherlands
    The Amsterdam University Medical Centers
Aug 2, 2023

Hiv Trial (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum))

Not yet recruiting
  • Hiv
  • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum)
  • (no location specified)
May 8, 2023

Bone Marrow Transplant, Stem Cell Transplant Trial in Aurora (Zoster Vaccine Recombinant)

Not yet recruiting
  • Bone Marrow Transplant
  • Stem Cell Transplant
  • Zoster Vaccine Recombinant
  • Aurora, Colorado
    University of Colorado Hospital
Mar 17, 2023

COVID-19 Trial in Nedlands (SCB-2019)

Completed
  • COVID-19
  • SCB-2019
  • Nedlands, Territory Western Australia, Australia
    Linear Clinical Research
Jan 28, 2022

Pertussis Immunization During Pregnancy & HIV Infection

Completed
  • Immunization; Infection
  • +3 more
  • TDaP
  • Brussels, Belgium
  • +1 more
Sep 29, 2022

Influenza Trial in Oxford (MF59 - ATIV)

Completed
  • Influenza
  • MF59 - ATIV
  • Oxford, United Kingdom
    Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropic
Nov 26, 2021

Rabies, Prevention Trial (PIKA-adjuvanted inactivated rabies vaccine, Rabipur)

Not yet recruiting
  • Rabies
  • Prevention
  • PIKA-adjuvanted inactivated rabies vaccine
  • Rabipur
  • (no location specified)
Dec 28, 2022

Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

Recruiting
  • Head and Neck Carcinoma
  • Adult Disease
  • HPVDC injection level dose 1
  • +3 more
  • Villejuif, France
    Gustave Roussy
Aug 17, 2023

RZV Vaccine (Shingrix ®) Trial in France, Switzerland (Recombinant Zoster Vaccine)

Not yet recruiting
  • RZV Vaccine (Shingrix ®)
  • Recombinant Zoster Vaccine
  • Bordeaux, France
  • +7 more
Oct 27, 2022

Influenza Trial in Lima (FLUAD Quadrivalent, FluQuadri)

Active, not recruiting
  • Influenza
  • FLUAD Quadrivalent
  • FluQuadri
  • Lima, Peru
  • +1 more
Sep 19, 2023

Influenza, Human Trial in Estonia, Germany, United States (aQIV, Comparator QIV)

Active, not recruiting
  • Influenza, Human
  • aQIV
  • Comparator QIV
  • Mobile, Alabama
  • +28 more
Jul 26, 2022

Hepatitis B Trial in Cambridge (GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine

Recruiting
  • Hepatitis B
  • GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
  • +4 more
  • Cambridge, United Kingdom
    GSK Investigational Site
Jan 12, 2023

Zoster, Systemic Lupus Erythematosus, Vaccine Reaction Trial in Seoul (Shingrix, Placebo)

Recruiting
  • Zoster
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 17, 2023

Cervical Intraepithelial Neoplasia Trial (HPV9 High formulation, HPV9 Medium formulation, HPV9 Low formulation)

Not yet recruiting
  • Cervical Intraepithelial Neoplasia
  • HPV9 High formulation
  • +3 more
  • (no location specified)
Aug 10, 2022